PROGRESSION-FREE SURVIVAL IN ADVANCED CLASSICAL HODGKIN LYMPHOMA PATIENTS WITH BULKY DISEASE AFTER ABVD WITHOUT RADIATION THERAPY IN ERA PET

被引：0
|
作者：
Puccini, B. [1 ]
Rigacci, L. [1 ]
Romano, I. [2 ]
Berti, V. [3 ]
Palazzo, M. [2 ]
Galli, E. [2 ]
Ciolli, G. [2 ]
Merlini, M. [2 ]
Vannucchi-, A. M. [1 ,2 ]
Nassi, L. [1 ]
机构：
[1] Careggi Hosp, Dept Haematol, Lymphoma Unit, Florence, Italy
[2] Univ Florence, Dept Expt & Clin Med, Florence, Italy
[3] Univ Florence, Dept Expt & Clin Biomed Sci, Nucl Med Unit, Florence, Italy
来源：
HAEMATOLOGICA | 2021年 / 106卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
D068
引用
收藏
页码：138 / 139
页数：2
相关论文
共 50 条
  • [1] Rituximab plus ABVD improves event free survival in patients with classical Hodgkin lymphoma who have pet positive disease after 2-3 cycles of therapy
    Wedgwood, A.
    Fanale, M.
    Fayad, L.
    McLaughlin, F.
    Hagemeister, E.
    Pro, B.
    Romaguera, J.
    Younes, A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 75 - 75
  • [2] FDG-PET AFTER TWO CYCLES OF CHEMOTHERAPY PREDICTS TREATMENT FAILURE AND PROGRESSION-FREE SURVIVAL IN ADVANCED PEDIATRIC HODGKIN LYMPHOMA
    Arora, B.
    Rangarajan, V.
    Shah, S.
    Dongre, A.
    Dwivedi, P.
    Laskar, S.
    Gujral, S.
    Shet, T.
    Chinnaswamy, G.
    Medhi, S.
    Qureshi, S.
    Banavali, S.
    PEDIATRIC BLOOD & CANCER, 2013, 60 : 33 - 33
  • [3] Consolidative Radiation Therapy (RT) for Advanced Stage Hodgkin's Lymphoma (HL) May Improve Progression Free Survival Than ABVD Alone for Adult Patients.
    Subramanian, K.
    Switchenko, J.
    Flowers, C. R.
    Esiashvili, N.
    Khan, M. K.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : E280 - E280
  • [4] Early treatment intensification with escalated BEACOPP after interim PET in advanced Hodgkin Lymphoma patients not responding to ABVD therapy
    Malkowski, B.
    Danielewicz, I.
    Lesniewski-Kmak, K.
    Zalewska, M.
    Zaucha, R.
    Szefer, J.
    Zaucha, J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 : S476 - S476
  • [5] Interim Functional Imaging Is an Independent Predictor of Progression-free Survival in Advanced Classical Hodgkin Lymphoma - A Real-world Analysis
    Damlaj, Moussab
    Al-Zahrani, Mohsen
    Syed, Ghulam
    Gmati, Giamal
    Alahmari, Bader
    Pasha, Tabrcz
    Alhejazi, Ayman
    Alaskar, Ahmed
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (01): : E71 - E79
  • [6] FDG-PET after two cycles of chemotherapy predicts treatment failure and progression-free survival in Hodgkin lymphoma
    Hutchings, M
    Loft, A
    Hansen, M
    Pedersen, LM
    Buhl, T
    Jurlander, J
    Buus, S
    Keiding, S
    D'Amore, F
    Boesen, AM
    Berthelsen, AK
    Specht, L
    BLOOD, 2006, 107 (01) : 52 - 59
  • [7] Comments on the study of correlation between progression-free and overall survival in patients with Hodgkin lymphoma
    Zeng, Y. -C.
    Xu, J. -N.
    Xiao, S. -Q.
    Ji, N. -N.
    Wang, Y.
    ANNALS OF ONCOLOGY, 2025, 36 (04) : 469 - 469
  • [8] Improved Progression-Free Survival for Bulky and Non-Bulky Advanced Stage Diffuse Large B-Cell Lymphoma With Consolidative Radiation Therapy: A Bi-Institutional Analysis
    Syed, Yusef A.
    Jiang, Cecilia
    Switchenko, Jeffrey
    Kirmani, Khadija
    Kelsey, Christopher
    Khan, Mohammad K.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (08)
  • [9] Volume of abnormal tumour tissue on FDG-PET - a predictor of progression-free survival in Hodgkin lymphoma?
    Hutchings, M
    Berthelsen, AK
    Jakobsen, AL
    Specht, L
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 63 (02): : S45 - S45
  • [10] Prediction of Progression-Free Survival with Brentuximab Vedotin Therapy for Relapsed Hodgkin Lymphoma: A Retrospective Analysis
    Houk, Anna
    Gopal, Ajay K.
    Libby, Edward N.
    Shustov, Andrei R.
    Green, Damian J.
    Philip, Mary
    Orozco, Johnnie J.
    Maloney, David G.
    Press, Oliver W.
    Smith, Stephen D.
    BLOOD, 2014, 124 (21)
12345